Bronchitis: Difference between revisions

Jump to navigation Jump to search
Line 34: Line 34:
==Treatment==
==Treatment==
[[Bronchitis medical therapy|Medical therapy]] | [[Bronchitis surgery|Surgical options]] | [[Bronchitis primary prevention|Primary prevention]]  | [[Bronchitis secondary prevention|Secondary prevention]] | [[Bronchitis cost-effectiveness of therapy|Financial costs]] | [[Bronchitis future or investigational therapies|Future therapies]]
[[Bronchitis medical therapy|Medical therapy]] | [[Bronchitis surgery|Surgical options]] | [[Bronchitis primary prevention|Primary prevention]]  | [[Bronchitis secondary prevention|Secondary prevention]] | [[Bronchitis cost-effectiveness of therapy|Financial costs]] | [[Bronchitis future or investigational therapies|Future therapies]]
==Prevention==
In 1985, University of Newcastle, Australia Professor Robert Clancy developed an oral vaccine for acute bronchitis. This vaccine was commercialised four years later as Broncostat.[http://www.biotechnology-innovation.com.au/innovations/pharmaceuticals/broncostat.html]


== References ==
== References ==

Revision as of 20:52, 23 January 2012